Trademark: 97221452
Status Date
Monday, August 7, 2023
Filing Date
Saturday, January 15, 2022
Published for Opposition
Tuesday, April 4, 2023
Abandoned Date
Thursday, August 3, 2023
5 Pharmaceutical and biologic preparations for immunological disorders, diseases, and conditions; Pharmaceutical and biologic preparations for the treatment of degenerative and inflammatory diseases and disorders, immune evasion, and immune dysfunction; Pharmaceutical and biologics preparations for use in ophthalmology, oncology, neurology, immunology, and fibrosis; Therapeutic agents in the nature of glycol-ligand nanoparticles and antibodies for modulating inflammation and other immune activities; Immunotherapies and glycol-therapeutics
42 Medical scientific testing for research purposes and research and development services in the fields of glycome, glycol-therapeutics, diseases and disorders involving the immune system, pharmaceuticals, and biologics; Providing medical scientific information in the fields of glycome, glycol-therapeutics diseases and disorders involving the immune system, pharmaceuticals, and biologics
Aug 7, 2023
Abandonment Notice E-Mailed - After Publication
Aug 7, 2023
Abandonment - After Publication
Aug 3, 2023
Teas Express Abandonment Received
May 30, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Feb 25, 2023
Approved For Pub - Principal Register
Feb 24, 2023
Teas/Email Correspondence Entered
Feb 23, 2023
Correspondence Received In Law Office
Feb 23, 2023
Teas Response To Office Action Received
Feb 8, 2023
Notification Of Non-Final Action E-Mailed
Feb 8, 2023
Non-Final Action E-Mailed
Feb 8, 2023
Non-Final Action Written
Jan 5, 2023
Teas/Email Correspondence Entered
Jan 4, 2023
Correspondence Received In Law Office
Jan 4, 2023
Teas Response To Office Action Received
Nov 1, 2022
Notification Of Non-Final Action E-Mailed
Nov 1, 2022
Non-Final Action E-Mailed
Nov 1, 2022
Non-Final Action Written
Oct 24, 2022
Assigned To Examiner
Jan 21, 2022
New Application Office Supplied Data Entered
Jan 19, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
